Basit öğe kaydını göster

dc.contributor.authorAbdel-Aziz, Alaa A-M.
dc.contributor.authorEl-Azab, Adel S.
dc.contributor.authorEkinci, Deniz
dc.contributor.authorSenturk, Murat
dc.contributor.authorSupuran, Claudiu T.
dc.date.accessioned2020-06-21T13:51:01Z
dc.date.available2020-06-21T13:51:01Z
dc.date.issued2015
dc.identifier.issn1475-6366
dc.identifier.issn1475-6374
dc.identifier.urihttps://doi.org/10.3109/14756366.2014.880696
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14550
dc.descriptionAbdel-Aziz, Alaa/0000-0002-3362-9337; El-Azab, Adel/0000-0001-7197-1515; Senturk, Murat/0000-0001-5968-7511en_US
dc.descriptionWOS: 000347956500013en_US
dc.descriptionPubMed: 24666299en_US
dc.description.abstractA series of arenesulfonyl-2-imidazolidinones incorporating methyl, isopropyl, methoxy, halogen and phenyl moieties were prepared and tested as possible inhibitors of two members of the pH regulatory enzyme family, carbonic anhydrase (CA; EC 4.2.1.1). The inhibitory potencies of the compounds against human isoforms hCA I and hCA II were analyzed by an esterase assay with 4-nitrophenyl acetate as substrate, and the inhibition constants (K-I) were calculated. Most compounds investigated here exhibited micromolar inhibition constants against the two isoenzymes. K-I values were in the range of 10.2-40.6 mu M for hCA I and of 13.1-31.4 mu M for hCA II, respectively. Most of the imidazolidinones showed interesting CA inhibitory efficacy, some of them having comparable affinity (for hCA I) as the clinically used sulfonamide acetazolamide (AZA), but their efficacy against hCA II was much lower compared to AZA.en_US
dc.description.sponsorshipDeanship of Scientific Research at King Saud UniversityDeanship of Scientific Research at King Saud University [RGP-VPP-163]en_US
dc.description.sponsorshipThe authors report no declarations of interest. The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project No. RGP-VPP-163.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.isversionof10.3109/14756366.2014.880696en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCarbonic anhydraseen_US
dc.subjectglaucomaen_US
dc.subjectimidazolidinoneen_US
dc.subjectinhibitoren_US
dc.titleInvestigation of arenesulfonyl-2-imidazolidinones as potent carbonic anhydrase inhibitorsen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume30en_US
dc.identifier.issue1en_US
dc.identifier.startpage81en_US
dc.identifier.endpage84en_US
dc.relation.journalJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster